España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Chugai Pharmaceutical
CHGCY
OTCPK
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$20.99
0.69
3.40%
At close: -
Get Report
Comment
Chugai Pharmaceutical (CHGCY) Forecast
News
Earnings
Chugai Pharmaceutical (CHGCY) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Chugai Pharmaceutical (OTC:CHGCY) Stock
Chugai Pharmaceutical Stock (OTC: CHGCY)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, December 12, 2022
Short Volatility Alert: Chugai Pharm Co
Christopher Sappo
Thursday, March 17, 2022
The Daily Biotech Pulse: AbbVie's Rinvoq Gets Label Expansion, AstraZeneca COVID Antibody Cocktail Authorized By UK Regulator, Stealth Touts Positive Data
Shanthi Rexaline
Tuesday, January 12, 2021
Global Markets Remain Mixed Amid China's Rally, Bitcoin Recovers
Mohit Manghnani
Tuesday, March 24, 2020
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Stocks That Hit 52-Week Highs On Tuesday
Benzinga Insights
Tuesday, February 11, 2020
Stocks That Hit 52-Week Highs On Tuesday
Lisa Levin
Tuesday, February 04, 2020
Stocks That Hit 52-Week Highs On Tuesday
Lisa Levin
Monday, February 03, 2020
Stocks That Hit 52-Week Highs On Monday
Lisa Levin
Thursday, January 30, 2020
Stocks That Hit 52-Week Highs On Thursday
Lisa Levin
Friday, January 24, 2020
Stocks That Hit 52-Week Highs On Friday
Lisa Levin
Tuesday, January 21, 2020
Stocks That Hit 52-Week Highs On Tuesday
Lisa Levin
Friday, January 17, 2020
Stocks That Hit 52-Week Highs On Friday
Lisa Levin
Thursday, January 09, 2020
Stocks That Hit 52-Week Highs On Thursday
Lisa Levin
Tuesday, December 17, 2019
Stocks That Hit 52-Week Highs On Tuesday
Lisa Levin
Tuesday, December 10, 2019
Stocks That Hit 52-Week Highs On Tuesday
Lisa Levin
Wednesday, October 30, 2019
The Daily Biotech Pulse: Novartis Program Placed On Partial Clinical Hold, Adcom Snub For Amag, Amgen Earnings
Shanthi Rexaline
Thursday, September 12, 2019
The Daily Biotech Pulse: Ardelyx Awaits Ruling On Constipation Drug, Double Dose Of Good News For Roche, Tocagen Flunks Brain Cancer Study
Shanthi Rexaline
Tuesday, July 30, 2019
New Stocks that Broke Through 52-Week Highs Tuesday Morning
Lisa Levin
Saturday, March 05, 2016
Chugai Announces Phase II Global Study Results of Nemolizumab in Late-breaking Research Forums at AAD
Benzinga
